Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Carlsmed (CARL) Equity Average (2024 - 2026)

Carlsmed filings provide 2 years of Equity Average readings, the most recent being $102.8 million for Q4 2025.

  • On a quarterly basis, Equity Average rose 250.4% to $102.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $102.8 million, a 250.4% increase, with the full-year FY2025 number at $14.1 million, changed N/A from a year prior.
  • Equity Average hit $102.8 million in Q4 2025 for Carlsmed, up from $11.8 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $102.8 million in Q4 2025 to a low of -$76.9 million in Q2 2025.